Skip to main content
. 2021 Mar 19;8:646412. doi: 10.3389/fmolb.2021.646412

FIGURE 4.

FIGURE 4

Engineered CRISPR/Cas13d sensing hTERT selectively induced bladder cancer cell apoptosis. Engineered CRISPR/Cas13d sensing hTERT have no effects on apoptosis in HFF (A). However, cell apoptosis was significantly increased by engineered CRISPR/Cas13d sensing hTERT in bladder cancer 5637 (B) and T24 (C) cells.